TransMedics Group, Inc. (TMDX) Total liabilities 2018–2025
TransMedics Group, Inc. (TMDX) total liabilities at each fiscal year-end, per SEC filings.
$595.3MFY2025 · since FY2018: $47.9M → $595.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $595.3M | +3.4% |
| FY2024 | $575.5M | +1.2% |
| FY2023 | $568.8M | +533.7% |
| FY2022 | $89.8M | +33.9% |
| FY2021 | $67.0M | +39.3% |
| FY2020 | $48.1M | -5.0% |
| FY2019 | $50.6M | +5.8% |
| FY2018 | $47.9M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More TMDX financial trends
TMDX RevenueTMDX Net incomeTMDX Net marginTMDX Gross profitTMDX Gross marginTMDX Operating incomeTMDX Operating marginTMDX Operating cash flowTMDX Free cash flowTMDX Capital expendituresTMDX Return on equityTMDX Stock buybacksTMDX Dividends paidTMDX Total assetsTMDX Shareholders’ equityTMDX overview →